E. Ohman J:Or Asset Management Ab Ultragenyx Pharmaceutical Inc. Transaction History

E. Ohman J:Or Asset Management Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 05, 2024	SELL	$36.99 - $48.71 $3.14 Million - $4.14 Million	-85,000 Closed	0 $0
Q4 2022 Apr 05, 2024	BUY	$33.72 - $46.33 $438,360 - $602,290	13,000 Added 18.06%	85,000 $3.94 Billion
Q3 2022 Apr 05, 2024	BUY	$39.96 - $66.14 $799,200 - $1.32 Million	20,000 Added 38.46%	72,000 $2.98 Billion
Q2 2022 Apr 05, 2024	BUY	$45.8 - $85.4 $2.38 Million - $4.44 Million	52,000 New	52,000 $3.1 Billion

286

78.6M

570K

228K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.86B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.